“…Interrogating receptor-ligand atomic contacts and using chemical similarity searches identifies more diverse and/or potent inhibitors (Cheltsov, et al, 2010; Wang, et al, 2009). Thus, a blueprint or pharmacophore of the entire Skp2 ligase inhibitor class is preliminary visualized, which may guide the rational synthesis of derivatives of C1, C2, C16, and C20 during future preclinical lead optimization stages.…”